Decreased eukaryotic initiation factors expression upon temozolomide treatment—potential novel implications for eIFs in glioma therapy

PURPOSE: Since glioma therapy is currently still limited until today, new treatment options for this heterogeneous group of tumours are of great interest. Eukaryotic initiation factors (eIFs) are altered in various cancer entities, including gliomas. The purpose of our study was to evaluate the pote...

Descripción completa

Detalles Bibliográficos
Autores principales: Krassnig, Stefanie, Leber, Stefan L., Orthmann, Andrea, Golob-Schwarzl, Nicole, Huber, Heinrich Johann, Wohlrab, Christina, Skofler, Christina, Pennauer, Mirjam, Raicht, Andrea, Birkl-Toeglhofer, Anna Maria, Naumann, Michael, Mahdy-Ali, Kariem, von Campe, Gord, Leoni, Marlene, Alcaniz, Joshua, Hoffmann, Jens, Wälchli, Thomas, Weis, Serge, Benesch, Martin, Haybaeck, Johannes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10638187/
https://www.ncbi.nlm.nih.gov/pubmed/37907716
http://dx.doi.org/10.1007/s11060-023-04451-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10638187/
https://www.ncbi.nlm.nih.gov/pubmed/37907716
http://dx.doi.org/10.1007/s11060-023-04451-y

Ejemplares similares